Ver­sant-backed, Bris­tol My­ers-stamped Re­pare Ther­a­peu­tics guns for $100M IPO

With a Bris­tol My­ers Squibb en­dorse­ment in tow, Ver­sant-backed can­cer drug de­vel­op­er Re­pare Ther­a­peu­tics has set its sights on a Nas­daq de­but.

On Fri­day, the …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER